15.08
price up icon2.94%   0.43
pre-market  Vorhandelsmarkt:  15.28   0.20   +1.33%
loading
Schlusskurs vom Vortag:
$14.65
Offen:
$14.79
24-Stunden-Volumen:
188.06K
Relative Volume:
0.79
Marktkapitalisierung:
$1.93B
Einnahmen:
$7.50M
Nettoeinkommen (Verlust:
$-81.89M
KGV:
0.2844
EPS:
53.0176
Netto-Cashflow:
$-63.58M
1W Leistung:
+37.59%
1M Leistung:
+44.51%
6M Leistung:
-14.22%
1J Leistung:
+99.74%
1-Tages-Spanne:
Value
$14.45
$15.11
1-Wochen-Bereich:
Value
$11.05
$16.07
52-Wochen-Spanne:
Value
$5.78
$22.00

Mesoblast Ltd Adr Stock (MESO) Company Profile

Name
Firmenname
Mesoblast Ltd Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
73
Name
Twitter
@Mesoblast
Name
Nächster Verdiensttermin
2025-02-24
Name
Neueste SEC-Einreichungen
Name
MESO's Discussions on Twitter

Vergleichen Sie MESO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MESO
Mesoblast Ltd Adr
15.08 1.40B 7.50M -81.89M -63.58M 53.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Mesoblast Ltd Adr Stock (MESO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-18 Herabstufung Jefferies Buy → Hold
2024-12-23 Herabstufung Jefferies Buy → Hold
2024-09-24 Hochstufung Maxim Group Hold → Buy
2024-08-29 Hochstufung Jefferies Hold → Buy
2024-07-23 Hochstufung Piper Sandler Neutral → Overweight
2023-08-31 Hochstufung Jefferies Hold → Buy
2023-08-07 Herabstufung Maxim Group Buy → Hold
2023-08-04 Herabstufung Piper Sandler Overweight → Neutral
2023-08-04 Herabstufung William Blair Outperform → Mkt Perform
2023-03-09 Eingeleitet William Blair Outperform
2022-12-06 Herabstufung Jefferies Buy → Hold
2022-09-06 Eingeleitet Piper Sandler Overweight
2021-04-07 Hochstufung Maxim Group Hold → Buy
2020-12-22 Herabstufung Maxim Group Buy → Hold
2020-12-04 Herabstufung Chardan Capital Markets Neutral → Sell
2020-10-22 Eingeleitet RBC Capital Mkts Sector Perform
2020-08-14 Bestätigt Maxim Group Buy
2020-05-28 Bestätigt H.C. Wainwright Buy
2019-01-31 Fortgesetzt H.C. Wainwright Buy
2018-03-22 Herabstufung Credit Suisse Neutral → Underperform
2018-02-28 Bestätigt Cantor Fitzgerald Buy
2017-08-31 Eingeleitet Oppenheimer Outperform
2017-06-08 Eingeleitet Cantor Fitzgerald Buy
Alle ansehen

Mesoblast Ltd Adr Aktie (MESO) Neueste Nachrichten

pulisher
Jul 18, 2025

Company’s Banking Stock: Dissecting a -4.28% Quarterly Revenue Decline Amid Growth - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Novagold Resources Inc (NG) Stock: A Year of Decreases and Increases - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

TV’s 2025 Market Dance: Down -20.11% – Time to Invest? - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Cango Inc ADR (CANG) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Mesoblast Ltd ADR Inc. (MESO) Price Performance: A Comparative Analysis with Competitors - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Innodata Inc (INOD) Stock: A Year of Market Movement, Down and Up - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

BILL Holdings Inc Inc. (BILL) Price Performance: A Fundamental Analysis Perspective - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Burford Capital Limited: Navigating Market Fluctuations with a 3.10B Market Cap - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Chagee Holdings Ltd. ADR (CHA) Stock: A Year of Highs and Lows - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Nano X Imaging Ltd (NNOX) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

LU’s Stock Dilemma: Lufax Holding Ltd ADR’s Market Performance and Outlook - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

ZTO’s Stock Market Adventure: -5.37% YTD Growth Amidst Volatility - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

MGRX’s Market Whiplash: -74.88% YTD Decline, -16.49% Plunge in 30 Days - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Mesoblast stock soars after reporting first Ryoncil sales - Investing.com India

Jul 18, 2025
pulisher
Jul 18, 2025

Sonim Technologies Inc (SONM) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jul 18, 2025
pulisher
Jul 17, 2025

Successful Commercial Launch of Ryoncil® - GlobeNewswire Inc.

Jul 17, 2025
pulisher
Jul 14, 2025

An In-Depth Look at Trident Digital Tech Holdings Ltd. ADR Inc. (TDTH) Price Performance During Market Crashes - investchronicle.com

Jul 14, 2025
pulisher
Jul 14, 2025

BTCM: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com

Jul 14, 2025
pulisher
Jul 11, 2025

Perspective Therapeutics Inc (CATX Stock: A Sea of Opportunity - investchronicle.com

Jul 11, 2025
pulisher
Jul 10, 2025

DallasNews Corporation (DALN) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jul 10, 2025
pulisher
Jul 08, 2025

Company’s Banking Shares: Up -3.01% from 52-Week Low, But Can the Momentum Hold? - investchronicle.com

Jul 08, 2025
pulisher
Jul 07, 2025

TSM’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Jul 07, 2025
pulisher
Jul 01, 2025

GE Vernova Inc (GEV) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com

Jul 01, 2025
pulisher
Jun 20, 2025

Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Jun 20, 2025
pulisher
May 06, 2025

All Markets & Instruments Available to Trade - Capital.com

May 06, 2025
pulisher
Mar 30, 2025

Mesoblast (ASX:MSB) Secures Medicaid Agreement for Ryoncil® - thecapitalclub.com.au

Mar 30, 2025
pulisher
Mar 20, 2025

UPDATED: Your guide to February Reporting Season 2020 - Morningstar.com.au

Mar 20, 2025
pulisher
Mar 03, 2025

21 Best-Performing Small-Cap Stocks for March 2025 - NerdWallet

Mar 03, 2025
pulisher
Feb 09, 2025

Why Mesoblast Ltd ADR (NASDAQ: MESO) Is Worth Including On Your Watchlist - Marketing Sentinel

Feb 09, 2025
pulisher
Feb 06, 2025

The 98.76% Simple Moving Average of Mesoblast Ltd ADR’s (MESO) Stock in the Past 200 Days - The News Heater

Feb 06, 2025
pulisher
Feb 01, 2025

Mesoblast Ltd ADR (NASDAQ:MESO) Shares Are Up 10.24 Percent In A Week – But Can The Gains Continue? - Marketing Sentinel

Feb 01, 2025
pulisher
Jan 31, 2025

ASX Lunch Wrap: ASX and gold reset record highs; but Origin cuts its LNG forecast - Stockhead

Jan 31, 2025
pulisher
Jan 10, 2025

Why are Mesoblast shares in a trading halt? - The Motley Fool Australia

Jan 10, 2025
pulisher
Jan 09, 2025

Mesoblast Limited Initiates Trading Halt Pending Financing Announcement - TipRanks

Jan 09, 2025
pulisher
Jan 08, 2025

ASX December health sector winners… and a 91pc drop for a trial-flopped stock - Stockhead

Jan 08, 2025
pulisher
Jan 02, 2025

Mesoblast (NASDAQ:MESO) Shares Gap UpWhat's Next? - MarketBeat

Jan 02, 2025
pulisher
Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024
pulisher
Dec 30, 2024

Mesoblast Stock Soars to 52-Week High, Hits $19.15 - Investing.com

Dec 30, 2024
pulisher
Dec 23, 2024

Mesoblast shares downgraded to hold by Jefferies By Investing.com - Investing.com South Africa

Dec 23, 2024
pulisher
Dec 20, 2024

Why the Mesoblast share price is diving 18% after an FDA win - The Motley Fool Australia

Dec 20, 2024
pulisher
Dec 19, 2024

Mesoblast share price rockets 30% on big US FDA news - The Motley Fool Australia

Dec 19, 2024
pulisher
Dec 16, 2024

Mesoblast stock soars to 52-week high, hits $12.21 - Investing.com

Dec 16, 2024
pulisher
Dec 03, 2024

Mesoblast Stock Soars to 52-Week High, Hits $12.19 - Investing.com

Dec 03, 2024
pulisher
Nov 13, 2024

Mesoblast stock soars to 52-week high, hits $11.1 - Investing.com

Nov 13, 2024
pulisher
Oct 08, 2024

JPMorgan Takes Substantial Stake in Mesoblast Ltd - TipRanks

Oct 08, 2024
pulisher
Sep 30, 2024

Mesoblast to raise $50m from top shareholder for product launch - Capital Brief

Sep 30, 2024
pulisher
Jul 22, 2024

Mesoblast: Rolling The Dice On Cellular Medicines (NASDAQ:MESO) - Seeking Alpha

Jul 22, 2024
pulisher
Apr 26, 2024

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners - Stockhead

Apr 26, 2024
pulisher
Apr 10, 2024

Mesoblast Limited: Back From The Dead (NASDAQ:MESO) - Seeking Alpha

Apr 10, 2024
pulisher
Mar 26, 2024

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - TradingView

Mar 26, 2024
pulisher
Mar 24, 2024

11 Best ASX Stocks To Buy Now - Yahoo Finance

Mar 24, 2024

Finanzdaten der Mesoblast Ltd Adr-Aktie (MESO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):